Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $93.6000 (-0.48%) ($91.6100 - $95.9800) on Wed. Aug. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 34 | Latest Price | $93.6000(-0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.35% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-9%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
Resistance Level | $99.42 | 5 Day Moving Average | $93.3(0.32%) | 10 Day Moving Average | $92.82(0.84%) | 20 Day Moving Average | $99.42(-5.85%) | To recent high | -22.1% | To recent low | 4.6% | Market Cap | $1.504b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |